NCT03372512Unknown不适用
Fluid Status Assessed by Bioelectrical Impedance Spectroscopy and Its Association With T1-mapping by Cardiovascular Magnetic Resonance Imaging
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Native T1-mapping
研究概览
简要总结
It is unclear to what extent systemic fluid overload has an impact on T1-mapping results by cardiovascular mangetic resonance imaging.
In this study, patients will undergo body composition monitoring assessing systemic fluid overload and T1-mapping using MOLLI by cardiovacular magnetic resonance imaging in order to investigate a possible association with each other.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •written informed consent
- •patient undergoing cardiovascular magnetic resonance imaging
排除标准
- •Unwillingness to participate
- •pregnancy
结局指标
主要结局
Native T1-mapping
时间窗: baseline
Association of fluid overload and native T1 values of left ventricular myocardium
Extracellular Volume by Cardiovascular magnetic resonance imaging
时间窗: baseline
Association of fluid overload and extracellular volume of left ventricular myocardium
次要结局
未报告次要终点
研究者
Dr. Andreas Kammerlander
MD
Medical University of Vienna
研究点 (1)
Loading locations...
相似试验
已完成
不适用
BIA Guided-fluid Management in Postinjury Open AbdomenDamage ControlTrauma AbdomenAcute Compartment SyndromeNCT03466684Nanjing PLA General Hospital140
尚未招募
不适用
Fluid Status and Body Composition Analysis by Bioelectrical Impedance in Patients After Cardiac Surgery (FLUBIACS)Cardiopulmonary DiseaseFluid OverloadNCT06498375University Medical Centre Ljubljana150
暂停
不适用
Bioimpedance Analysis in Chronic Heart FailureHeart FailureNCT02662439Peter Studinger240
Unknown
不适用
Bio Electrical Impedance Analysis to Monitor Fluid Status During Deresuscitation Strategy in Continuous Renal Replacement TherapyFluid OverloadNCT05160467Hospices Civils de Lyon23
已完成
不适用
Correlation of SOZO BIS Measures With CardioMEMS PA PressureNYHA Class III Heart FailureNCT02939053ImpediMed Limited3
